Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mega Genomics Limited ( (HK:6667) ) just unveiled an update.
Mega Genomics Limited has announced a delay in the publication of its 2024 Annual Report, which was initially required to be dispatched by April 30, 2025, as per the Listing Rules of the Hong Kong Stock Exchange. This delay has also led to the continued suspension of trading of the company’s shares, which has been in effect since April 1, 2025. The company plans to announce the new dispatch date for the report and provide further updates as necessary, advising shareholders and potential investors to exercise caution.
More about Mega Genomics Limited
YTD Price Performance: -34.43%
Average Trading Volume: 108,169
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.61B
Learn more about 6667 stock on TipRanks’ Stock Analysis page.